Gadeta is a clinical stage biotechnology company developing a first-in-class cellular immunotherapy for the treatment of cancer, using a number of proprietary T-cell engineering and manufacturing technologies.We are using a number of proprietary T-cell engineering and manufacturing technologies. We are pioneering the development of αβ T-cells engineered to express defined γδ T-cell receptors that can specifically recognize...
Gadeta is a clinical stage biotechnology company developing a first-in-class cellular immunotherapy for the treatment of cancer, using a number of proprietary T-cell engineering and manufacturing technologies.We are using a number of proprietary T-cell engineering and manufacturing technologies. We are pioneering the development of αβ T-cells engineered to express defined γδ T-cell receptors that can specifically recognize cancer cells Gadeta uses the unique characteristics of γδ T cell receptors (TCRs) in the broad recognition of both haematological and solid tumour cells and their potential use treatment of advanced malignancies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.